Ignite Creation Date:
2024-05-06 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 2:15 PM
Study NCT ID:
NCT05075512
Status:
RECRUITING
Last Update Posted:
2021-10-12
First Post:
2021-08-09
Brief Title:
The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer
Sponsor:
Zhejiang Cancer Hospital
Organization:
Zhejiang Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-09
First Submit QC Date:
October 10 2021
Study First Post Date:
2021-10-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-10
Last Update Post Date:
2021-10-12
Last Update Post Date Type:
ACTUAL